These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1126372)

  • 1. Effects of various psychoative drugs on the metabolism of delta-tetrahydrocannabinol by rats in vitro and in vivo.
    Siemens AJ; De Nie LC; Kalant H; Khanna JM
    Eur J Pharmacol; 1975 Mar; 31(1):136-47. PubMed ID: 1126372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of SKF 525-A on the analgesic and barbiturate-potentiating activity of delta 9-tetrahydrocannabinol in mice and rats.
    Sofia RD; Barry H
    Pharmacology; 1983; 27(4):223-36. PubMed ID: 6314397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism.
    Widman M; Nordqvist M; Dollery CT; Briant RH
    J Pharm Pharmacol; 1975 Nov; 27(11):842-8. PubMed ID: 1493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The delay of the behavioral effects of 9 -tetrahydrocannabinol in rats by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Peterson DW; Cohen GM; Sparber SB
    Life Sci I; 1971 Dec; 10(24):1381-6. PubMed ID: 5146321
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of delta-1-tetrahydrocannabinol by the rat in vivo and in vitro.
    Siemens AJ; Kalant H
    Biochem Pharmacol; 1975 Apr; 24(7):755-62. PubMed ID: 235932
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of delta1-tetrahydrocannabinol by rats tolerant to cannabis.
    Siemens AJ; Kalant H
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1154-66. PubMed ID: 4451887
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism and autoradiographic distribution of delta-8- and delta-9-tetrahydrocannabinol in some organs of the monkey Callithrix jacchus.
    Just WW; Erdmann G; Thel S; Werner G; Wiechmann M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):219-25. PubMed ID: 806815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
    Johansson E; Gillespie HK; Halldin MM
    J Anal Toxicol; 1990; 14(3):176-80. PubMed ID: 2165199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex difference in the oxidative metabolism of delta 9-tetrahydrocannabinol in the rat.
    Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1991 Apr; 41(8):1187-94. PubMed ID: 1848985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo metabolism of 11-hydroxy-delta-tetrahydrocannabinol to two carboxylic acids and the effects of SKF 525-A, cobaltous chloride and phenobarbital on their formation in rats.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    Chem Pharm Bull (Tokyo); 1980 Jul; 28(7):2154-7. PubMed ID: 6256091
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of barbiturates in rats tolerant to delta 9-tetrahydrocannabinol.
    McMillan DE; Hardwick WC; Wells JD
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):4-14. PubMed ID: 6312913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of 14C-delta1-THC in rat plasma after intravenous injection and smoking.
    Fehr KO; Kalant H
    Eur J Pharmacol; 1974 Jan; 25(1):1-8. PubMed ID: 4435008
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in tissue distribution of chlordecone (kepone) in the rat following phenobarbital or SKF-525A administration.
    Aldous CN; Chetty CS; Desaiah D
    J Toxicol Environ Health; 1983 Mar; 11(3):365-72. PubMed ID: 6188850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of delta 9-tetrahydrocannabinol-induced teratogenicity by stimulation and inhibition of its metabolism.
    Harbison RD; Mantilla-Plata B; Lubin DJ
    J Pharmacol Exp Ther; 1977 Aug; 202(2):455-65. PubMed ID: 886474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
    Solinas M; Zangen A; Thiriet N; Goldberg SR
    Eur J Neurosci; 2004 Jun; 19(12):3183-92. PubMed ID: 15217374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-9-tetrahydrocannabinol: localization in body fat.
    Kreuz DS; Axelrod J
    Science; 1973 Jan; 179(4071):391-3. PubMed ID: 4682965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol.
    Jones G; Pertwee RG
    Br J Pharmacol; 1972 Jun; 45(2):375-7. PubMed ID: 5048656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.
    Wall ME; Sadler BM; Brine D; Taylor H; Perez-Reyes M
    Clin Pharmacol Ther; 1983 Sep; 34(3):352-63. PubMed ID: 6309462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic interactions of phencyclidine (PCP) and delta 9-tetrahydrocannabinol (THC) in the rat.
    Lamé MW; Husain S
    Pharmacol Biochem Behav; 1986 Oct; 25(4):827-33. PubMed ID: 3024181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.